Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 10, 2016 4:18 PM ET

Biotechnology

Company Overview of EPIRUS Biopharmaceuticals, Inc.

Executive Profile

Mark H. N. Corrigan M.D.

AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 8 different industries.

See Board Relationships
57$1,900,884
As of Fiscal Year 2014

Background

Dr. Mark H. N. Corrigan, M.D. served as the Chief Executive Officer and President of Zalicus Inc. from January 2010 to June 2014. Dr. Corrigan is a seasoned life sciences executive. Dr. Corrigan joined the specialty pharmaceutical company Sepracor Inc. in 2003. He served as an Executive Vice President of Research & Development of Sunovion Pharmaceuticals Inc. (formerly, Sepracor Inc.) from April 21, 2003 to December 2009. He has over 20 years of experience in treating ...

Corporate Headquarters

699 Boylston Street
Boston, Massachusetts 02116

United States

Phone: 617-600-4313
Fax: --

Board Members Memberships

2014-Present
Chairman
2015-Present
Director
2015-Present
Director and Chairman of Compensation Committee
2015-Present
Director

Education

BA
University of Virginia
MD
University of Virginia

Other Affiliations

Annual Compensation

Salary$278,833
Total Annual Compensation$278,833

Stocks Options

Restricted Stock Awards$367,500
All Other Compensation$1,060,129
Exercisable Options$156,654
Total Number of Options$156,654

Total Compensation

Total Annual Cash Compensation$1,368,962
Total Short Term Compensation$278,833
Other Long Term Compensation$1,427,629
Total Calculated Compensation$1,900,884
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EPIRUS Biopharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.